Can Gram-positive cocci in chains be a contaminant in blood?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Gram-positive cocci in chains can indeed be contaminants in blood cultures, particularly if other blood cultures drawn at the same time are negative, suggesting contamination with skin flora. This consideration is crucial in the context of preventing the spread of vancomycin resistance, as highlighted in the recommendations for preventing the spread of vancomycin resistance by the Hospital Infection Control Practices Advisory Committee (HICPAC) 1. When encountering gram-positive cocci in chains in blood cultures, it is essential to differentiate between contamination and true bacteremia, which may require treatment. Factors to consider include the number of positive blood culture sets, the patient's clinical presentation, and the presence of risk factors for bacteremia.

  • Common contaminants include skin flora such as coagulase-negative staphylococci, which can be introduced into blood samples during collection.
  • The identity of the organism, once fully characterized, also plays a significant role in determining the appropriate course of action.
  • Empiric treatment with antibiotics may be initiated in critically ill patients, but the decision to continue or discontinue should be based on complete microbiology results and the clinical picture.
  • Training of phlebotomists and other personnel to minimize microbial contamination of specimens is vital, as emphasized in the HICPAC recommendations 1, to prevent inappropriate administration of vancomycin and other antibiotics.

From the Research

Gram-Positive Cocci in Chains as Contaminants in Blood

  • Gram-positive cocci in chains can be a contaminant in blood, but they can also be a cause of infection, particularly in cases of streptococcal or enterococcal bacteremia 2, 3.
  • The presence of gram-positive cocci in chains in blood cultures can be evaluated using diagnostic tests such as the Verigene Gram-positive blood culture assay, which has an overall concordance of 89.7% with culture 2.
  • A treatment algorithm can be developed based on the identification of gram-positive cocci in chains in blood cultures, allowing for targeted treatment of infections caused by these organisms 2.
  • In some cases, gram-positive cocci in chains may be resistant to commonly used antibiotics, such as vancomycin, and may require treatment with alternative agents, such as linezolid, daptomycin, or tigecycline 4, 5, 6.
  • Rapid identification of gram-positive cocci in chains in blood cultures is important for early reporting and administration of proper antimicrobial treatment, and can be achieved using diagnostic tests such as latex agglutination tests or the tube coagulase test 3.

References

Related Questions

What antibiotic is recommended for treating gram-positive cocci infections?
What antibiotic covers gram-positive cocci?
What are the best antibiotic (abx) choices for a Gram-positive cocci infection?
What antibiotics are used to treat rare gram-positive cocci infections, such as Methicillin-Resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus?
What is the recommended antibiotic treatment for gram-positive cocci bacteremia?
What are the treatment options for congenital scoliosis associated with Neurofibromatosis type 1 (NF1) with a Cobb angle greater than 60 degrees in the T10 spine segment?
What is the diagnosis and treatment for coronary microvascular dysfunction (CMVD)?
What is the diagnosis for Gram-positive cocci in chains, specifically Streptococci (Streptococcus)?
What is the prognosis for a 64-year-old male with liver disease, previous ascites, leukopenia (White Blood Cell count of 1), massively enlarged spleen due to Splenic Marginal Zone Lymphoma, on lactulose (lactulose) and recently prescribed zanubrutinib (Bruton's tyrosine kinase inhibitor) for lymphoma, with a history of Transjugular Intrahepatic Portosystemic Shunt (TIPS) procedure and hyperbilirubinemia (elevated bilirubin levels)?
What is the pathophysiology of coronary microvascular dysfunction (CMVD)?
What is the cause of chronic upper abdominal pain, considering differential diagnoses of Irritable Bowel Syndrome (IBS) versus Gastroesophageal Reflux Disease (GERD) versus gastritis versus constipation versus gallbladder disease versus pancreatitis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.